The Cervix Cancer and Normal Tissue Array includes 80 tissue cores representing 80 individual cases, covering a comprehensive range of cervical cancer stages and grades, along with matched normal tissue controls. This array provides a valuable resource for high-throughput biomarker discovery, drug target validation, and histopathological analysis. Each core is annotated with detailed clinical data, including tumor stage, grade, and pathology, enabling precise correlation between molecular markers and disease progression. Ideal for use in immunohistochemistry (IHC), in situ hybridization, and other tissue-based assays.